相关实验视频
Updated: Sep 11, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
在动脉样硬化中的炎症和脂质新陈代谢调节中的JNK
Dan Tang1, Yi Yao2, Xing Xiang1
1Department of Clinical Laboratory Medicine, Institution of microbiology and infectious diseases, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China; Hunan Provincial Key Laboratory of Multi-omics And Artificial Intelligence of Cardiovascular Diseases, University of South China, Hengyang, Hunan, China; Clinical Research Center for Myocardial Injury in Hunan Province, Hengyang, Hunan, China; Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
动脉样硬化涉及复杂的调节,其发展的中心是c-Jun N-终端激酶 (JNK). 准JNK可能为这种系统性动脉疾病提供新的治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 分子医学是分子医学.
- 病理生理学 病理生理学
背景情况:
- 动脉样硬化是一种全身性动脉疾病,以脂质积累,炎症和内皮功能障碍为标志.
- 复杂的,多因素调节驱动动动脉硬化病原体.
- c-Jun N-终端激酶 (JNK),一种压力激活的激酶,与疾病发展有关.
研究的目的:
- 审查JNK在动脉样硬化中的作用.
- 突出JNK作为动脉样硬化的潜在治疗标.
主要方法:
- 这是一篇综述性文章,综合了有关JNK在动脉样硬化中的作用的现有研究.
- 文献综述侧重于分子机制和器官间影响.
主要成果:
- 简基因调节关键的病原性过程,包括氧化应激,脂质代谢和炎症.
- 血管损伤激活JNK,放大炎症和疾病的进展.
- 基因通过肝脏和脏等器官的代谢和炎症途径影响血管健康.
结论:
- 简基因在动脉样硬化的发病过程中起着中心作用.
- 准JNK通路为动脉样硬化症提供了一个有前途的治疗策略.
- 了解JNK的器官间作用对于开发有效的治疗方法至关重要.
相关概念视频
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...

